Cardiff Lexington Corp (OTCPK:CDIX)
$ 1.75 -0.050 (-2.78%) Market Cap: 26.75 Mil Enterprise Value: 58.20 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 24/100

Q4 2025 Cardiff Lexington Corp Earnings Call Transcript

Mar 16, 2026 / 03:00PM GMT
Release Date Price: $3.4 (+1.19%)

Key Points

Positve
  • Cardiff Lexington Corp (CDIX) achieved a 40% increase in revenue for the full year 2025 compared to 2024, driven by higher patient volume and a shift towards more complex, higher-value surgical procedures.
  • The company expanded its Nova Ortho and Spine operations to 11 locations across Florida and Georgia, demonstrating growth and commitment to underserved areas.
  • Cardiff Lexington Corp (CDIX) maintained a strong adjusted EBITDA profitability for the full year, with an adjusted EBITDA of 1.8 million.
  • The company is actively positioning itself for an uplisting to a major US stock exchange, which is expected to enhance visibility, liquidity, and access to capital.
  • Cardiff Lexington Corp (CDIX) has a high industry-leading collection rate of over 95% through alternative payment methods, such as automotive insurance settlements and private payments.
Negative
  • The company reported a net loss of 5.5 million for the full year 2025, compared to a net loss of 3.3 million in 2024, indicating increased financial challenges.
  • Interest expenses significantly increased to 6.8 million for the full year 2025, impacting the company's profitability.
  • Revenue for the fourth quarter of 2025 declined to 2.8 million from 3.1 million in the same quarter of the previous year, due to variances in accounts receivable collection and reduced patient volume during the holiday season.
  • Total liabilities increased to 26 million as of December 31, 2025, primarily due to a higher outstanding balance on the line of credit.
  • The company faces limitations in working capital, which restricts its ability to fully capitalize on growth opportunities and improve profitability.
Operator

Good morning, everyone and thank you for participating in today's conference call to discuss Cardiff Lexington's financial results for the fourth quarter and year ended December 31, 2025. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn a call over to John Nesbitt and Walter Frank of IMS Investor Relations. Please go ahead.

Walter Frank
Cardiff Lexington Corp - Investor Relations

Thank you, operator. I would like to welcome everybody to the call. Hosting the call today are Cardiff Lexington's CEO, Alex Cunningham; and CFO, Matt Schaeffer. I would like to take a moment to read the Safe Harbor statement.

This conference call contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934 as amended. These forward-looking statements in terms such as anticipate, expect, intend, may, will, should, or other comparable terms involve risks and uncertainties because they relate to events and depend on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot